Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This study seeks to understand how frailty, a term that describes people who are more vulnerable stressors such as a new medical problem, affects the outcomes and quality of life in adult patients with gynecologic cancer.
Full description
PRIMARY OBJECTIVE:
I. Assess the risk factors associated with frailty in newly diagnosed gynecologic cancer participants.
SECONDARY OBJECTIVES:
I. Compare primary quality of life endpoint of "healthy days at home" between non-frail and frail participants (primary quality of life endpoint).
II. Compare other perioperative, oncologic, and quality of life outcomes between non-frail and frail participants.
OUTLINE: This is an observational study.
All new patients being evaluated for a new diagnosis of gynecologic cancer by the University of California, San Francisco (UCSF) Gynecologic Oncology service and the Dana-Farber Cancer Institute will be recruited in both the outpatient or inpatient setting. Study participants will be enrolled at the time of diagnosis and followed for up to one year after undergoing surgery for cancer.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
225 participants in 1 patient group
Loading...
Central trial contact
Nathalie Halley
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal